In this study, we demonstrated that [111In]In-DOTA-Ahx-R954, a radiolabelled derivative of the B1R antagonist, can be used to detect the endogenous expression of B1R in glioblastoma cells. This evidence concerns the gene BDKRB1 and glioblastoma.